News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Avalon Ventures Closes $75 Million Seventh Fund For Biotech Start-Ups
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
3/4/2005 - Avalon Ventures has raised $75 million in its seventh fund. The firm plans to maintain its current strategy of investing in early-stage drug development and wireless companies.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Earnings
Amgen Advocates For ‘Pro-Growth Tax Policy’ Instead of Tariffs to Boost Domestic Manufacturing
May 2, 2025
·
2 min read
·
Tristan Manalac
Earnings
Lilly Unfazed as CVS Picks Novo’s Side in Obesity Market Battle
May 1, 2025
·
3 min read
·
Annalee Armstrong
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
·
3 min read
·
Annalee Armstrong
Earnings
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts
May 1, 2025
·
3 min read
·
Annalee Armstrong
